Abeona Days Of Inventory On Hand from 2010 to 2024
| ABEO Stock | USD 4.26 0.05 1.19% |
Days Of Inventory On Hand | First Reported 2010-12-31 | Previous Quarter 315.28 | Current Value 391.36 | Quarterly Volatility 407.63226059 |
Check Abeona Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abeona main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.2 M, Interest Expense of 397.1 K or Selling General Administrative of 18.1 M, as well as many exotic indicators such as Price To Sales Ratio of 29.07, Dividend Yield of 0.0 or PTB Ratio of 7.59. Abeona financial statements analysis is a perfect complement when working with Abeona Therapeutics Valuation or Volatility modules.
Abeona | Days Of Inventory On Hand |
Latest Abeona Therapeutics' Days Of Inventory On Hand Growth Pattern
Below is the plot of the Days Of Inventory On Hand of Abeona Therapeutics over the last few years. It is Abeona Therapeutics' Days Of Inventory On Hand historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Abeona Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Days Of Inventory On Hand | 10 Years Trend |
|
Days Of Inventory On Hand |
| Timeline |
Abeona Days Of Inventory On Hand Regression Statistics
| Arithmetic Mean | 190.93 | |
| Geometric Mean | 0.03 | |
| Coefficient Of Variation | 213.50 | |
| Mean Deviation | 248.53 | |
| Median | 0.000082 | |
| Standard Deviation | 407.63 | |
| Sample Variance | 166,164 | |
| Range | 1.6K | |
| R-Value | (0.26) | |
| Mean Square Error | 166,964 | |
| R-Squared | 0.07 | |
| Significance | 0.35 | |
| Slope | (23.59) | |
| Total Sum of Squares | 2.3M |
Abeona Days Of Inventory On Hand History
About Abeona Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Abeona Therapeutics income statement, its balance sheet, and the statement of cash flows. Abeona Therapeutics investors use historical funamental indicators, such as Abeona Therapeutics's Days Of Inventory On Hand, to determine how well the company is positioned to perform in the future. Although Abeona Therapeutics investors may use each financial statement separately, they are all related. The changes in Abeona Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Abeona Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Abeona Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Abeona Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 315.28 | 391.36 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Abeona Therapeutics Correlation against competitors. To learn how to invest in Abeona Stock, please use our How to Invest in Abeona Therapeutics guide.Note that the Abeona Therapeutics information on this page should be used as a complementary analysis to other Abeona Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Abeona Stock analysis
When running Abeona Therapeutics' price analysis, check to measure Abeona Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abeona Therapeutics is operating at the current time. Most of Abeona Therapeutics' value examination focuses on studying past and present price action to predict the probability of Abeona Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abeona Therapeutics' price. Additionally, you may evaluate how the addition of Abeona Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |
Is Abeona Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abeona Therapeutics. If investors know Abeona will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abeona Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.18) | Revenue Per Share 0.164 | Quarterly Revenue Growth (1.00) | Return On Assets (0.47) | Return On Equity (2.61) |
The market value of Abeona Therapeutics is measured differently than its book value, which is the value of Abeona that is recorded on the company's balance sheet. Investors also form their own opinion of Abeona Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Abeona Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abeona Therapeutics' market value can be influenced by many factors that don't directly affect Abeona Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abeona Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abeona Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abeona Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.